Skip to main content
search
In the News

Medical Innovation Must Shift Focus from Common Problems to Unsolvable Ones

IN THE NEWS
January 12, 2024

Medical Innovation Must Shift Focus from Common Problems to Unsolvable Ones

MedCity News
VIEW ARTICLE
Back to News

Related News

Filter

MMI Completes World’s First Robotic Preclinical Study in Neurosurgery with Symani® Surgical System

What’s next for surgical robotics? Medtech vet Mark Toland places his bets

MMI Builds Global Momentum with Multiple Distribution Agreements and Regulatory Approvals

MMI Wins Innovative Start-up in 2024 Surgical Robotics Industry Awards

Robot-assisted surgery: Big step in the millimeter range

MMI Completes First Symani® Clinical Cases in the U.S. Following FDA Commercial Authorization

MMI Receives FDA Authorization to Commercialize Symani® Surgical System in the U.S. 

MMI Raises $110 Million in Series C Financing

Micro Instruments, Massive Impact: The Surgibots Podcast featuring The Symani Surgical System

Medical Innovation Must Shift Focus from Common Problems to Unsolvable Ones

MMI and ab medica Partner to Expand Access to Symani® Surgical System

MMI to Present at the 42nd Annual J.P. Morgan Healthcare Conference

OUR TECHNOLOGY

Symani Surgical System

How it Works

Benefits of Robotic-Assisted Microsurgery

Starting a Robotics Program

CLINICAL APPLICATIONS

Breast Cancer

Lymphedema

Head & Neck Cancer

Trauma

EDUCATION

Research & Publications

Symani Training and Certification

ABOUT MMI

Our Story

Our People

Careers

Investors

Patent Notice

Whistleblower Reporting

MMI
5022 Gate Parkway,
Building 500,
Jacksonville, FL 32256
Product Information: connect@mmimicro.com
Symani Support: techsupport@mmimicro.com

Privacy Notice

Cookie Policy

Terms of Use

Global Indications

The Symani Surgical System is authorized for use in the U.S. by the FDA and is a CE marked medical device. Clinical indications vary by geography. Refer to global indications for more information. © 2024 Medical Microinstruments, Inc. All Rights Reserved.

To watch this Professional Presentation, please submit your details.

To watch this Professional Presentation, please submit your details.

To watch this Professional Presentation, please submit your details.

To watch this Professional Presentation, please submit your details.

To watch this Professional Presentation, please submit your details.

To watch this Professional Presentation, please submit your details.

To watch this Microchat, please submit your details.